The Roles of Cathelicidin LL-37 in Inflammatory Bowel Disease.
Quick Facts
What This Study Found
Key Numbers
How They Did This
Why This Research Matters
What This Study Doesn't Tell Us
Trust & Context
- Original Title:
- The Roles of Cathelicidin LL-37 in Inflammatory Bowel Disease.
- Published In:
- Inflammatory bowel diseases, 22(8), 1986-91 (2016)
- Authors:
- Sun, Lihua, Wang, Wensheng, Xiao, Weidong, Yang, Hua
- Database ID:
- RPEP-03123
Evidence Hierarchy
Read More on RethinkPeptides
Related articles coming soon.
Cite This Study
https://rethinkpeptides.com/research/RPEP-03123APA
Sun, Lihua; Wang, Wensheng; Xiao, Weidong; Yang, Hua. (2016). The Roles of Cathelicidin LL-37 in Inflammatory Bowel Disease.. Inflammatory bowel diseases, 22(8), 1986-91. https://doi.org/10.1097/MIB.0000000000000804
MLA
Sun, Lihua, et al. "The Roles of Cathelicidin LL-37 in Inflammatory Bowel Disease.." Inflammatory bowel diseases, 2016. https://doi.org/10.1097/MIB.0000000000000804
RethinkPeptides
RethinkPeptides Research Database. "The Roles of Cathelicidin LL-37 in Inflammatory Bowel Diseas..." RPEP-03123. Retrieved from https://rethinkpeptides.com/research/sun-2016-the-roles-of-cathelicidin
Access the Original Study
Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.
This study breakdown was produced by the RethinkPeptides research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.